Historical oxy News Stories

Occidental: OxyChem Sale, Q4 Beat, Shares Rise Now

Occidental Petroleum’s recent quarter and the completion of the OxyChem divestiture delivered concrete financial improvements: stronger-than-expected Q4 results, a meaningful reduction in debt to about $15 billion, raised dividend, and CapEx discipline. These developments pushed OXY to a 52-week high and improved investor confidence, while leaving valuation and cyclicality as watchpoints.

OXY Rally Driven by Oil Spike, Permian CapEx Plans

Occidental (OXY) saw a near-term rally tied to a sharp oil-price uptick and reinforced operational spending in the Permian. Analysts lifted price targets but kept neutral ratings, signaling a commodity-driven move rather than a fundamental re-rating. Key items: $7.0–7.2B 2025 CapEx, heavy Permian allocation, and robust well-count plans.

Occidental Rally: OxyChem Sale, Oil Price Surge Q1

Occidental Petroleum’s stock moved sharply after a $9.7B OxyChem divestiture, aggressive debt-reduction plans and a powerful January oil-price rebound. Operational changes in the Delaware Basin and a modest institutional buy signal further investor focus on balance-sheet repair amid near-term commodity sensitivity.